Ricardo Fernandes

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Diffusion Weighted Imaging

Radical Prostatectomy

Renal Cell Carcinoma

Top Venues

Current oncology (Toronto, Ont.)

Clinical case reports

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Anish Tejura, Ricardo Fernandes, Stacey Hubay, Matthew Scott Ernst, Mario Valdes, Anupam Batra
Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology. Current oncology (Toronto, Ont.) 31 (8) (2024)
Prathana Nathan, Adnan Rajeh, Meh Noor, Gabriel Boldt, Ricardo Fernandes
Antibody-Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data. Current oncology (Toronto, Ont.) 31 (4) (2024)
Anish Tejura, Ricardo Fernandes, Stacey Hubay, Matthew Scott Ernst, Mario Valdes, Anupam Batra
Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology. Current oncology (Toronto, Ont.) 31 (8) (2024)
Anish Tejura, Ricardo Fernandes, Stacey Hubay, Matthew Scott Ernst, Mario Valdes, Anupam Batra
Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology. Current oncology (Toronto, Ont.) 31 (8) (2024)
Prathana Nathan, Adnan Rajeh, Meh Noor, Gabriel Boldt, Ricardo Fernandes
Antibody-Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data. Current oncology (Toronto, Ont.) 31 (4) (2024)
Prathana Nathan, Adnan Rajeh, Meh Noor, Gabriel Boldt, Ricardo Fernandes
Antibody-Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data. Current oncology (Toronto, Ont.) 31 (4) (2024)
Prathana Nathan, Adnan Rajeh, Meh Noor, Gabriel Boldt, Ricardo Fernandes
Antibody-Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data. Current oncology (Toronto, Ont.) 31 (4) (2024)
Prathana Nathan, Adnan Rajeh, Meh Noor, Gabriel Boldt, Ricardo Fernandes
Antibody-Drug Conjugates in the Treatment of Genitourinary Cancers: An Updated Review of Data. Current oncology (Toronto, Ont.) 31 (4) (2024)
Neil E Fleshner, Rashid K Sayyid, Aaron Richard Hansen, Joseph L K Chin, Ricardo Fernandes, Eric Winquist, Theodorus H Van der Kwast, Joan Sweet, Katherine Lajkosz, Miran Kenk, Karen Hersey, Rosette Veloso, Doron Berlin, Jaime O Herrera-Caceres, Srikala S Sridhar, Madeleine Moussa, Antonio Finelli, Robert J Hamilton, Girish S Kulkarni, Alexandre R Zlotta, Anthony M Joshua
Neoadjuvant Cabazitaxel Plus Abiraterone/Leuprolide Acetate in High-Risk Prostate Cancer Patients: ACDC-RP Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ricardo Fernandes, Terry L Ng, Mashari Jemaan Alzahrani, Jacques Raphael, Phillip Blanchette, Morgan Black, Carol Stober, Gregory R Pond, David Cella, Lisa Vandermeer, Mohammed Ibrahim, Mark J Clemons, null null
A Multi-Centre Randomized Study Comparing Two Standard of Care Chemotherapy Regimens for Lower-Risk HER2-Positive Breast Cancer. Current oncology (Toronto, Ont.) 30 (8) (2023)
Rayyan Syed Kamal, Arleigh Dean, Hanna Dutt, Adnan Rajeh, Ricardo Fernandes
Hypoglycemia as first presentation of presumed immune checkpoint inhibitor-induced type 1 diabetes. Clinical case reports 11 (9) (2023)
Victoria Purcell, Beatrice Preti, Ricardo Fernandes
Suspected immune checkpoint inhibitor-induced pulmonary sarcoid reaction in metastatic renal cell carcinoma. Clinical case reports 10 (7) (2022)